Literature DB >> 10027668

Irritable bowel syndrome: disease definition and symptom description.

N J Talley1.   

Abstract

According to the Rome criteria, both abdominal pain and disordered defecation must be present to make a diagnosis of the irritable bowel syndrome (IBS). While established morphologic or physiologic tests are unavailable to diagnosis IBS, there are candidate biological markers; the evidence overall supports the concept that IBS is a true disease of gut function. The Rome criteria were derived from epidemiological and clinical studies, and were developed by consensus. The clinical and epidemiological evidence supporting current IBS diagnostic criteria and their limitations are summarised in this review. Symptom based subgroups of IBS may be identifiable based on symptom predominance although this remains controversial; a classification is proposed here. The Rome criteria represent a starting point; well designed studies are now needed to refine and if necessary revise current criteria.

Entities:  

Mesh:

Year:  1998        PMID: 10027668     DOI: 10.1080/11024159850191193

Source DB:  PubMed          Journal:  Eur J Surg Suppl        ISSN: 1102-416X


  4 in total

Review 1.  Developmental biology of the enteric nervous system: pathogenesis of Hirschsprung's disease and other congenital dysmotilities.

Authors:  Michael D Gershon; Elyanne M Ratcliffe
Journal:  Semin Pediatr Surg       Date:  2004-11       Impact factor: 2.754

2.  Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters.

Authors:  J J Chen; Z Li; H Pan; D L Murphy; H Tamir; H Koepsell; M D Gershon
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

Review 3.  From Hans Selye's discovery of biological stress to the identification of corticotropin-releasing factor signaling pathways: implication in stress-related functional bowel diseases.

Authors:  Yvette Taché; Stefan Brunnhuber
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

4.  Hyperimmune egg powder for the treatment of irritable bowel syndrome: A case series.

Authors:  Mark W Morningstar
Journal:  J Chiropr Med       Date:  2004
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.